ABEO - SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Abeona Therapeutics Inc. - ABEO | Benzinga
NEW YORK, April 25, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Abeona Therapeutics Inc. ("Abeona" or the "Company") (NASDAQ:ABEO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
The investigation concerns whether Abeona and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
[Click here for information about joining the class action]
On April 22, 2024, Abeona issued a press release "announc[ing] a regulatory update for prademagene zamikeracel (pz-cel)." Abeona's press release stated that "[t]he U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) in response to the Company's Biologics License Application (BLA) for ...